Search results
From Proteopedia
You searched for Tsitsanou,_K.E.
There is no page with the exact title "Tsitsanou,_K.E.". The search results for "Tsitsanou,_K.E." are displayed below. You can create a page titled Tsitsanou,_K.E. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Tsitsanou KE (43 bytes)
1: List of pages with the keyword Tsitsanou KE - Category:Tsitsanou, K E (45 bytes)
1: List of pages with the keyword Tsitsanou, K E - Category:Tsitsanou, K.E (45 bytes)
1: List of pages with the keyword Tsitsanou, K.E
Page text matches
- 1uzu (5,254 bytes)
2: ...phorylase b in complex with indirubin-5'-sulphonate==
3: ...uzu]], [[Resolution|resolution]] 2.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1UZU FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - Category:Tsitsanou KE (43 bytes)
1: List of pages with the keyword Tsitsanou KE - 1b4d (4,977 bytes)
2: ...=AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE==
3: ...b4d]], [[Resolution|resolution]] 2.00Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1B4D FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1bx3 (4,858 bytes)
2: ...TS ON GLYCOGEN PHOSPHORYLASE ACTIVITY AND STRUCTURE==
3: ...bx3]], [[Resolution|resolution]] 2.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1BX3 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1c50 (5,371 bytes)
2: ...L ALLOSTERIC BINDING SITE OF GLYCOGEN PHOSPHORYLASE B==
3: ...c50]], [[Resolution|resolution]] 2.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1C50 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1c8k (5,345 bytes)
2: ...OGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE==
3: ...c8k]], [[Resolution|resolution]] 1.76Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1C8K FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.76Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1c8l (4,816 bytes)
2: ...ASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE==
3: ...c8l]], [[Resolution|resolution]] 2.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1C8L FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>
7: ...scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr> - 1e1y (5,457 bytes)
2: ...ogen phosphorylase by binding at the inhibitor site==
3: ...e1y]], [[Resolution|resolution]] 2.23Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1E1Y FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.23Å</td></tr>
7: ...scene name='pdbligand=PO3:PHOSPHITE+ION'>PO3</scene></td></tr> - 1fs4 (4,929 bytes)
2: ...es and the implications for structure-based drug design==
3: ...fs4]], [[Resolution|resolution]] 2.38Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FS4 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.38Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1ftq (5,005 bytes)
2: ...ES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN==
3: ...ftq]], [[Resolution|resolution]] 2.35Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FTQ FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.35Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1ftw (4,946 bytes)
2: ...ES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN==
3: ...ftw]], [[Resolution|resolution]] 2.36Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FTW FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.36Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1fty (4,951 bytes)
2: ...ES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN==
3: ...fty]], [[Resolution|resolution]] 2.38Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FTY FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.38Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1fu4 (4,957 bytes)
2: ...ES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN==
3: ...fu4]], [[Resolution|resolution]] 2.36Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FU4 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.36Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1fu7 (4,913 bytes)
2: ...ES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN==
3: ...fu7]], [[Resolution|resolution]] 2.36Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FU7 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.36Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1fu8 (4,924 bytes)
2: ...ES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN==
3: ...fu8]], [[Resolution|resolution]] 2.35Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1FU8 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.35Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1gfz (5,316 bytes)
2: ...OGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE==
3: ...gfz]], [[Resolution|resolution]] 2.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1GFZ FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 1ggn (4,609 bytes)
2: ...es and the implications for structure-based drug design==
3: ...ggn]], [[Resolution|resolution]] 2.36Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1GGN FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.36Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> - 4ij7 (4,287 bytes)
2: ...otein 48 from Anopheles gambiae (AgamOBP48) with PEG==
3: ...ij7]], [[Resolution|resolution]] 2.25Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=4IJ7 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.25Å</td></tr>
7: ...74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL'>PEU</scene></td></tr> - 3amv (6,253 bytes)
2: ...F GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG==
3: ...amv]], [[Resolution|resolution]] 2.10Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=3AMV FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr>
7: ...scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr> - 1z62 (5,580 bytes)
2: ...llosteric site. Broad specificities of the two sites==
3: ...z62]], [[Resolution|resolution]] 1.90Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1Z62 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>
7: ...me='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr>
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
